Safety of the second dose of the ChAdOx1 nCoV‐19 vaccine in people with persistent anti–platelet factor 4 antibodies

Corresponding Author

Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand

Research Unit in Translational Hematology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand

Correspondence

Noppacharn Uaprasert, Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital Rama IV Rd, Pathumwan, Bangkok 10330, Thailand.

Email: drnoppacharn@yahoo.com

Search for more papers by this author

留言 (0)

沒有登入
gif